## What went well
- Maintainer and implementation owner kept PR #51 within four allowed paths. The two new tests inspect identity, descriptors and nested contents without consuming status again (src/summary.test.mjs:266-316); all 28 tests and six declared commands passed.
- Exact-head approval and the retained authorized merge receipt distinguish assessment from actual integration. Current CI verifies the integrated revision.

## What went wrong
- The integration record initially had no post-merge CI evidence (R49-CI); later dispatched CI resolved verification, not automatic scheduling. Root cause and cross-work-item recurrence are unknown.
- Product citation verification emitted PRODUCT103, and dependency installation reported four low-severity audit findings (R49-PRODUCT103, R49-AUDIT). Neither establishes a source defect in this test-only delivery. No stale affected guidance was established.

## Start doing
- Automation maintainer: retain CI event type beside revision and outcome, as this review does, so a dispatched verification is not mistaken for an automatically scheduled run.
- Product and dependency owners: triage the deferred diagnostics using the references above before proposing any separately reviewed correction.

## Stop doing
- Do not equate missing or skipped evidence with failed tests, or use green routing checks as behavioral proof. This is a retained review rule, not a claim of recurring misconduct.

## Improvement candidates
- **CI evidence continuity — owner: automation maintainer; reference R49-CI.** Observed gap: initial merged receipt had no ci.yml run. Smallest useful guard candidate: a receipt-level test that keeps review blocked while required post-merge evidence is missing and distinguishes workflow_dispatch from automatic events. Reproduce with the retained missing-CI receipt before correction; then supply matching dispatched CI and check that verification clears without claiming scheduling. No automation source defect is established; any guard needs its own review and regression proof.
- **Actor reachability triage — owner: product owner; reference R49-PRODUCT103.** Observed diagnostic: FR-SUMMARY-001 has no actor path. Reproduce with the retained citation-verification command on the unchanged model. Smallest useful guard candidate: a focused reachability fixture, only after the owner decides whether a relationship is intended; verify the diagnostic before correction and expected outcome after it. Product/provider guidance changes require separate review and authorized product-change flow.
- **Dependency advisory triage — owner: dependency maintainer; reference R49-AUDIT.** Observed diagnostic: four low-severity findings without advisory details. First reproduce the reported audit in a separately authorized maintenance task and identify affected packages. Smallest useful guard candidate: retain advisory IDs and disposition, with before/after advisory evidence and full regression checks for any proposed dependency correction. No forced upgrade or broad audit gate is proposed here.

These are follow-up candidates recorded in this review, not newly opened issues or permission changes. No recurrence across work items, attention-time or cost measurement is inferred.